Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Finasteride helps treat hair loss by blocking enzyme activity.

High androgen levels often cause female hirsutism and infertility.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

5α-reductases increase epitestosterone's effect on androgen receptors.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Finasteride side effects in young men may be linked to specific gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.